首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

PHARMACOGENOMICS JOURNAL
ISSN：1470-269X

PHARMACOGENOMICS JOURNAL

PHARMACOGENOMICS J
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学3区
年发文量：36
影响因子：2.9
JCR分区：Q2

基本信息

《药物基因组学杂志》是一本印刷和电子期刊，致力于快速发表药物基因组学及其临床应用的原创研究。主要报道领域包括：个性化药物遗传变异对药物毒性和疗效的影响与药物作用相关的多态性的鉴定和功能表征药效学和药代动力学变异以及药物疗效将基因组计划和蛋白质组学的新进展整合到临床医学、药理学和治疗学中基因组科学的临床应用药物开发的新基因组靶点的鉴定药物基因组学的潜在益处。
1470-269XSCIE/Scopus收录
2.9
点击查看最新影响趋势>
2.4
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
GENETICS & HEREDITY 遗传学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：GENETICS & HEREDITY
SCIE
Q2
76/192
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
150/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：GENETICS & HEREDITY
SCIE
Q2
84/192
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
145/353
78
36
点击查看年发文量趋势图>
7%0较慢,6-12周-医学-药学
3.4%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
86.11%34.44%4.59%
CiteScore：6.30
SJR：0.694
SNIP：0.832
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Pharmacology
Q2
100 / 321
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Genetics
Q2
114 / 348
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Molecular Medicine
Q2
74 / 177

期刊高被引文献

Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0067-3
Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0089-x
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0113-1
Drug–drug–gene interactions and adverse drug reactions
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0122-0
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0069-1
Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0080-6
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0072-6
Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0096-y
Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0085-1
Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0110-4
Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0111-3
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0081-5
Gender based differences, pharmacogenetics and adverse events in chronic pain management
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0118-9
Precision dosing of warfarin: open questions and strategies
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0083-3
Opportunities for pharmacists to integrate pharmacogenomics into clinical practice
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0119-8
Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0103-3
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
来源期刊：The pharmacogenomics journalDOI：10.1038/s41397-019-0125-x
Genetic Polymorphisms Associated with Reactive Oxygen Species and Blood Pressure Regulation
来源期刊：The pharmacogenomics journalDOI：10.1038/s41397-019-0082-4
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0068-2
Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0090-4
OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0131-z
Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits
来源期刊：The pharmacogenomics journalDOI：10.1038/s41397-019-0074-4
HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0092-2
Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0098-9
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0070-8
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0066-4
Genetic contribution to lipid target achievement with statin therapy: a prospective study
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0136-7
Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adults
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0112-2
A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0101-5
The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0116-y
Ketamine in seizure management and future pharmacogenomic considerations
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0120-2
Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0139-4
The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0114-0
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0117-x
Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0135-8
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0078-0
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0130-0
Genome-Wide Meta-analysis of Variant-by-Diuretic Interactions as Modulators of Lipid Traits in Persons of European and African Ancestry
来源期刊：The pharmacogenomics journalDOI：10.1038/s41397-019-0132-y
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0087-z
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0106-0
An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0126-9
Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0133-x
Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0097-x
A genome-wide association study of tramadol metabolism from post-mortem samples
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0088-y
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0073-5
Correction: Polymorphisms at phase I-metabolizing enzyme and\n hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis\n patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0084-2
HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0121-1
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0129-6
Analysis of galanin receptor GALR2 in multiple sclerosis
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0100-6
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients
来源期刊：The Pharmacogenomics JournalDOI：10.1038/s41397-019-0109-x

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
GENETICS & HEREDITY 遗传学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
GENETICS & HEREDITY 遗传学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
GENETICS & HEREDITY 遗传学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否